Acute Respiratory Failure in a Patient With Idiopathic Pulmonary Fibrosis Following Nebulized and Intravenous Stem Cell Therapy

Kelly L. Cervellione, Janaya Raynor, Parool Desai, Craig A. Thurm

Abstract


Idiopathic pulmonary fibrosis (IPF) is an uncommon disease with a poor prognosis. Recently, two medications were approved to slow progression of disease. However, due to the limited treatment options available, patients and their families often look to experimental and off-label treatments for support. One such option is stem cell therapy, which can be delivered in a variety of ways. Stem cells are being utilized both in and out of the context of closely monitored clinical trials. However, there is little evidence regarding the safety and efficacy of stem cell therapy for patients with IPF. Here we describe a case of a patient who received intravenous and nebulized stem cell therapy, which was followed by an acute exacerbation of his IPF. The exacerbation was successfully treated with corticosteroids and supportive care.




J Med Cases. 2017;8(10):301-304
doi: https://doi.org/10.14740/jmc2876e

Keywords


Idiopathic pulmonary fibrosis; Stem cell therapy; Exacerbation

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org    elmer.editorial@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.